Related Experiment Video
Updated: Nov 9, 2025

Rapid Detection of Neurodevelopmental Phenotypes in Human Neural Precursor Cells NPCs
Published on: March 2, 2018
Dyrk1a Mutations Cause Undergrowth of Cortical Pyramidal Neurons via Dysregulated Growth Factor Signaling
Jenna A Levy1, Christy W LaFlamme2, George Tsaprailis3
1Department of Neuroscience, The Scripps Research Institute, Jupiter, Florida; Doctoral Program in Chemical and Biological Sciences, The Skaggs Graduate School of Chemical and Biological Sciences at Scripps Research, Jupiter, Florida.
Background:
Mutations in DYRK1A are a cause of microcephaly, autism spectrum disorder, and intellectual disability; however, the underlying cellular and molecular mechanisms are not well understood.
Methods:
We generated a conditional mouse model using Emx1-cre, including conditional heterozygous and homozygous knockouts, to investigate the necessity of Dyrk1a in the cortex during development. We used unbiased, high-throughput phosphoproteomics to identify dysregulated signaling mechanisms in the developing Dyrk1a mutant cortex as well as classic genetic modifier approaches and pharmacological therapeutic intervention to rescue microcephaly and neuronal undergrowth caused by Dyrk1a mutations.
Results:
We found that cortical deletion of Dyrk1a in mice causes decreased brain mass and neuronal size, structural hypoconnectivity, and autism-relevant behaviors. Using phosphoproteomic screening, we identified growth-associated signaling cascades dysregulated upon Dyrk1a deletion, including TrkB-BDNF (tyrosine receptor kinase B-brain-derived neurotrophic factor), an important regulator of ERK/MAPK (extracellular signal-regulated kinase/mitogen-activated protein kinase) and mTOR (mammalian target of rapamycin) signaling. Genetic suppression of Pten or pharmacological treatment with IGF-1 (insulin-like growth factor-1), both of which impinge on these signaling cascades, rescued microcephaly and neuronal undergrowth in neonatal mutants.
Conclusions:
Altogether, these findings identify a previously unknown mechanism through which Dyrk1a mutations disrupt growth factor signaling in the developing brain, thus influencing neuronal growth and connectivity. Our results place DYRK1A as a critical regulator of a biological pathway known to be dysregulated in humans with autism spectrum disorder and intellectual disability. In addition, these data position Dyrk1a within a larger group of autism spectrum disorder/intellectual disability risk genes that impinge on growth-associated signaling cascades to regulate brain size and connectivity, suggesting a point of convergence for multiple autism etiologies.
Insights
DYRK1A mutations disrupt brain growth and connectivity by affecting growth factor signaling. Therapies targeting these pathways may rescue microcephaly and neuronal undergrowth in related developmental disorders.
Area of Science:
- Neuroscience
- Developmental Biology
- Genetics
Background:
- DYRK1A gene mutations are linked to microcephaly, autism spectrum disorder (ASD), and intellectual disability.
- The precise cellular and molecular mechanisms underlying these conditions remain poorly understood.
Purpose of the Study:
- To investigate the role of Dyrk1a in cortical development using a conditional mouse model.
- To identify signaling pathways dysregulated by Dyrk1a mutations and explore therapeutic interventions.
Main Methods:
- Generated Emx1-cre conditional knockout mice (heterozygous and homozygous) for Dyrk1a.
- Utilized high-throughput phosphoproteomics to analyze signaling in Dyrk1a mutant cortices.
- Employed genetic and pharmacological approaches to rescue developmental defects.
Main Results:
- Cortical Dyrk1a deletion caused reduced brain mass, neuronal size, hypoconnectivity, and autism-related behaviors.
- Identified dysregulated growth factor signaling, including TrkB-BDNF, ERK/MAPK, and mTOR pathways.
- Genetic suppression of Pten or IGF-1 treatment rescued microcephaly and neuronal undergrowth.
Conclusions:
- DYRK1A is critical for regulating growth factor signaling in brain development.
- Disruption of this pathway by DYRK1A mutations contributes to neurodevelopmental disorders.
- Identified a convergence point for multiple ASD/intellectual disability risk genes affecting brain growth and connectivity.
More Related Videos
08:22A Novel Strategy Combining Array-CGH, Whole-exome Sequencing and In Utero Electroporation in Rodents to Identify Causative Genes for Brain Malformations
Published on: December 1, 2017
09:07Genetic Manipulation of Cerebellar Granule Neurons In Vitro and In Vivo to Study Neuronal Morphology and Migration
Published on: March 17, 2014
Related Concept Videos
Enzyme-linked Receptors
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Abnormal Proliferation
The Ras Gene
Ras is a...
Notch Signaling Pathway
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not...
PI3K/mTOR/AKT Signaling Pathway